Search results
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 1 day agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 5 hours agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
Column: Anatomy of a smear — Fauci faces the House GOP's clown show about COVID
LA Times via Yahoo News· 5 hours agoThe House GOP attacks Anthony Fauci, one of America's most accomplished public health officials,...
Study reveals persistent risk of death, symptoms in COVID survivors at 3 years
Center for Infectious Disease Research and Policy· 5 days agoCOVID-19 patients hospitalized with the wild-type virus in 2020 were at a 29% higher risk for death...
Researchers take step toward development of universal COVID-19 antibodies
The Parsons Sun· 5 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium ...
The FLiRT subvariants are rising: How bad will a California summer COVID wave get?
Los Angeles Times· 3 days agoWhile California’s COVID numbers look relatively good, officials say FLiRT’s rise shows the need to...
Whooping cough outbreaks: Why is pertussis on the rise in several countries?
LiveScience· 7 days agoCases of whooping cough, or pertussis, have been on the rise in various countries, including the...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 4 days agoThe NHS has commenced a clinical trial offering personalised cancer vaccines being developed by BioNTech and Genentech to patients. The first patient was...
Cancer vaccine hailed as 'game-changer'
Newsweek· 4 days agoCancer patients in the U.K. are about to get personalized cancervaccines as part of a new trial. Unlike vaccines for diseases like the flu or ...
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 4 hours agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
